Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 29
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 1401 | BRIDGESTONE AMERICAS TIRE OPERATIONS | 10 | 00% | 0 | 10 | 2023–2024 |
| 1402 | BUERKERT WERKE KG | 10 | 00% | 0 | 10 | 2023–2025 |
| 1403 | CANCER RESEARCH TECHNOLOGY | 10 | 110% | 2 | 7 | 2022–2025 |
| 1404 | CARBIOS | 10 | 00% | 0 | 10 | 2022–2025 |
| 1405 | CAREFUSION 2200 | 10 | 00% | 1 | 9 | 2023–2026 |
| 1406 | CERAMIC DATA SOLUTIONS | 10 | 220% | 0 | 8 | 2022–2025 |
| 1407 | CHENGDU AODA BIOTECHNOLOGY | 10 | 00% | 0 | 10 | 2022–2026 |
| 1408 | COATEX | 10 | 00% | 1 | 9 | 2022–2025 |
| 1409 | CONTINENTAL AUTONOMOUS MOBILITY GERMANY | 10 | 110% | 0 | 9 | 2023–2025 |
| 1410 | CRISPR THERAPEUTICS | 10 | 00% | 4 | 6 | 2022–2026 |
| 1411 | CUE BIOPHARMA | 10 | 00% | 0 | 10 | 2022–2024 |
| 1412 | DAL TILE | 10 | 110% | 0 | 9 | 2022–2026 |
| 1413 | DANIELI AUTOMATION | 10 | 220% | 0 | 8 | 2022–2026 |
| 1414 | DIGICERT | 10 | 00% | 0 | 10 | 2023–2024 |
| 1415 | DIGITALINSIGHTS | 10 | 110% | 0 | 9 | 2022–2025 |
| 1416 | DMG MORI | 10 | 110% | 0 | 9 | 2022–2025 |
| 1417 | DOLBY INTELLECTUAL PROPERTY LICENSING | 10 | 00% | 0 | 10 | 2024–2026 |
| 1418 | DONG A ST | 10 | 550% | 0 | 5 | 2022–2026 |
| 1419 | DRIV AUTOMOTIVE | 10 | 00% | 0 | 10 | 2024–2024 |
| 1420 | E LEAD ELECTRONIC | 10 | 110% | 0 | 9 | 2022–2025 |
| 1421 | EAGLE INDUSTRY | 10 | 110% | 0 | 9 | 2022–2025 |
| 1422 | EQUISTAR CHEMICALS LP | 10 | 00% | 3 | 7 | 2023–2025 |
| 1423 | ETA GREEN POWER | 10 | 220% | 1 | 7 | 2022–2023 |
| 1424 | FMC AGRICULTURAL SOLUTIONS A S | 10 | 00% | 0 | 10 | 2023–2026 |
| 1425 | FUJI OIL HOLDINGS | 10 | 110% | 2 | 7 | 2021–2025 |
| 1426 | FUTAMURA KAGAKU | 10 | 110% | 0 | 9 | 2022–2026 |
| 1427 | GCP APPLIED TECHNOLOGIES | 10 | 00% | 0 | 10 | 2022–2025 |
| 1428 | GE ENERGY POWER CONVERSION TECHNOLOGY | 10 | 110% | 0 | 9 | 2019–2024 |
| 1429 | GREFFEX | 10 | 00% | 0 | 10 | 2022–2023 |
| 1430 | H TTENES ALBERTUS CHEMISCHE WERKE GESELLSCHAFT MIT BESCHR NKTER HAFTUNG | 10 | 110% | 2 | 7 | 2022–2025 |
| 1431 | HAIHONG ELECTRIC | 10 | 330% | 3 | 4 | 2022–2025 |
| 1432 | HALEON UK IP | 10 | 00% | 0 | 10 | 2024–2026 |
| 1433 | HERCULES | 10 | 00% | 1 | 9 | 2022–2025 |
| 1434 | HFI INNOVATION | 10 | 880% | 0 | 2 | 2019–2024 |
| 1435 | HITACHI INDUSTRY CONTROL SOLUTIONS | 10 | 220% | 0 | 8 | 2022–2026 |
| 1436 | HITHIUM TECH HK | 10 | 110% | 0 | 9 | 2023–2025 |
| 1437 | HUHTAMAKI FLEXIBLE PACKAGING GERMANY KG | 10 | 00% | 0 | 10 | 2022–2025 |
| 1438 | HUSKY INJECTION MOLDING SYSTEMS | 10 | 110% | 0 | 9 | 2022–2026 |
| 1439 | IDEAL POWER | 10 | 220% | 0 | 8 | 2023–2026 |
| 1440 | INTERNATIONAL N H DENMARK APS | 10 | 00% | 0 | 10 | 2023–2026 |
| 1441 | INVISTA TEXTILES U K | 10 | 110% | 1 | 8 | 2022–2026 |
| 1442 | IQM FINLAND | 10 | 00% | 3 | 7 | 2022–2024 |
| 1443 | ISHIDA EUROPE | 10 | 00% | 4 | 6 | 2022–2024 |
| 1444 | J VAN WALRAVEN HOLDING | 10 | 00% | 0 | 10 | 2022–2025 |
| 1445 | JIANGSU KANGRUI NEW MATERIAL TECHNOLOGY | 10 | 220% | 0 | 8 | 2023–2025 |
| 1446 | JUNO THERAPEUTICS | 10 | 00% | 1 | 9 | 2022–2025 |
| 1447 | KAHA | 10 | 770% | 0 | 3 | 2020–2024 |
| 1448 | KEMIN INDUSTRIES | 10 | 330% | 0 | 7 | 2022–2026 |
| 1449 | KLINGELNBERG | 10 | 00% | 1 | 9 | 2022–2025 |
| 1450 | KOCH TECHNOLOGY SOLUTIONS UK | 10 | 330% | 1 | 6 | 2022–2025 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →